Oncology Institute (DFPH) Capital Expenditures (2021 - 2026)

Oncology Institute has reported Capital Expenditures for 6 years, with the latest figure at $1.0 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 217.68% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (up 11.61% YoY), and the FY2025 full-year result was $3.2 million, down 15.54% from the prior year.
• Capital Expenditures for Q1 2026 stood at $1.0 million, down from $1.1 million in the prior quarter.
• The five-year high for Capital Expenditures was $1.8 million in Q1 2023, with the low at -$3.5 million in Q4 2022.
• Historically, Capital Expenditures has averaged $741058.8 across 5 years, with a median of $1.0 million in 2022.
• Annual changes were most pronounced in 2022 — Capital Expenditures slumped 505.74% — and 2025, when it jumped 250.25%.
• Oncology Institute's Capital Expenditures stood at -$3.5 million in 2022, then jumped by 124.36% to $861000.0 in 2023, then jumped by 103.83% to $1.8 million in 2024, then sank by 39.6% to $1.1 million in 2025, then fell by 1.7% to $1.0 million in 2026.
• The last three Capital Expenditures figures came in at $1.0 million (Q1 2026), $1.1 million (Q4 2025), and $604000.0 (Q3 2025), per Business Quant data.